Mark Massaro
Stock Analyst at BTIG
(4.58)
# 277
Out of 5,043 analysts
152
Total ratings
55.97%
Success rate
21.92%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Buy | $200 → $210 | $192.22 | +9.25% | 14 | Oct 23, 2025 | |
| TEM Tempus AI | Maintains: Buy | $85 → $96 | $91.58 | +4.83% | 4 | Oct 22, 2025 | |
| PSNL Personalis | Maintains: Buy | $6 → $11 | $9.68 | +13.64% | 2 | Oct 22, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $125 → $140 | $130.66 | +7.15% | 5 | Oct 22, 2025 | |
| XGN Exagen | Maintains: Buy | $11 → $13 | $11.91 | +9.15% | 4 | Oct 22, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $60 → $75 | $63.50 | +18.11% | 18 | Oct 22, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $14 → $19 | $17.12 | +10.98% | 6 | Oct 22, 2025 | |
| GH Guardant Health | Maintains: Buy | $70 → $80 | $70.85 | +12.91% | 5 | Sep 25, 2025 | |
| CDNA CareDx | Reiterates: Buy | $22 | $14.51 | +51.62% | 4 | Sep 23, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $1.26 | +98.41% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $6 → $9 | $13.39 | -32.79% | 7 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.54 | - | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.91 | - | 8 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 → $225 | $147.53 | +52.51% | 2 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $647.40 | -10.41% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $10.16 | +106.69% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.43 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $4.79 | +67.01% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $4.20 | +90.48% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $23.96 | +25.21% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.54 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $100.35 | +198.95% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $73.95 | -32.39% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $180.26 | -37.87% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $275.66 | -40.14% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $29.48 | +171.37% | 9 | Sep 10, 2018 |
Natera
Oct 23, 2025
Maintains: Buy
Price Target: $200 → $210
Current: $192.22
Upside: +9.25%
Tempus AI
Oct 22, 2025
Maintains: Buy
Price Target: $85 → $96
Current: $91.58
Upside: +4.83%
Personalis
Oct 22, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $9.68
Upside: +13.64%
GeneDx Holdings
Oct 22, 2025
Maintains: Buy
Price Target: $125 → $140
Current: $130.66
Upside: +7.15%
Exagen
Oct 22, 2025
Maintains: Buy
Price Target: $11 → $13
Current: $11.91
Upside: +9.15%
Exact Sciences
Oct 22, 2025
Maintains: Buy
Price Target: $60 → $75
Current: $63.50
Upside: +18.11%
Adaptive Biotechnologies
Oct 22, 2025
Maintains: Buy
Price Target: $14 → $19
Current: $17.12
Upside: +10.98%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $70 → $80
Current: $70.85
Upside: +12.91%
CareDx
Sep 23, 2025
Reiterates: Buy
Price Target: $22
Current: $14.51
Upside: +51.62%
Lucid Diagnostics
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.26
Upside: +98.41%
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $13.39
Upside: -32.79%
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.54
Upside: -
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.91
Upside: -
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $147.53
Upside: +52.51%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $647.40
Upside: -10.41%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $10.16
Upside: +106.69%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.43
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $4.79
Upside: +67.01%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $4.20
Upside: +90.48%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $23.96
Upside: +25.21%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.54
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $100.35
Upside: +198.95%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $73.95
Upside: -32.39%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $180.26
Upside: -37.87%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $275.66
Upside: -40.14%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $29.48
Upside: +171.37%